MIRA INFORM REPORT

 

 

Report Date :           

20.12.2011

 

IDENTIFICATION DETAILS

 

Name :

BOSTON VIETNAM PHARMACEUTICAL JOINT STOCK COMPANY 

 

 

Registered Office :

43 Road No.8 VSIP I , Thuan An Town, Binh Duong Province

 

 

Country :

Vietnam

 

 

Financials (as on) :

31.12.2009

 

 

Year of Establishment :

2007

 

 

Com. Reg. No.:

3700843113

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Manufacture of pharmaceuticals, medicinal chemical and botanical products

 

 

No. of Employees :

250  persons

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

Vietnam

b1

b1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


SUBJECT IDENTIFICATION & LEGAL FORM

 

English Name

 

BOSTON VIETNAM PHARMACEUTICAL JOINT STOCK COMPANY

Vietnamese Name

 

CONG TY CO PHAN DUOC PHAM BOS TON VIET NAM

Type of Business

 

Joint stock company

Year Established

 

2007

Business Registration No.

 

3700843113

Latest adjustment

 

28 Jun 2011

Place of Registration

 

Business Registration Office- Planning and Investment Department of Binh Duong province

Registered capital

 

N/A

Tax code

 

3700843113

Total Employees

 

250

 

 

 

company ADDRESSES

 

Head Office

Address

 

43 Road No.8 VSIP I , Thuan An Town, Binh Duong Province, Vietnam

Telephone

 

(84 650) 3769606

Fax

 

(84 650) 3769601

Website

 

www.bostonpharma.com.vn

 

Transaction office in Ho Chi Minh

Address

 

76 Le Lai AB Building Floor 11, Ben Thanh Ward, 1st District, Ho Chi Minh City, Vietnam

Telephone

 

(84 8) 35210505

Fax

 

(84 8) 35210606

 

 

DIRECTORS

 

1. NAME

 

Mr. LUONG DANG KHOA

Position

 

Director

Nationality

 

Vietnamese

 

2. NAME

 

Ms. HUYNH THI PHUONG LAN

Position

 

Human Resource Manager

Nationality

 

Vietnamese

 

3. NAME

 

Ms. TON NU PHUONG QUYNH

Position

 

Chief Accountant

Nationality

 

Vietnamese

Email

 

quynh.ton@bostonpharma.com.vn

 

 

BUSINESS NATURE AND ACTIVITIES

 

Manufacture of pharmaceuticals, medicinal chemical and botanical products

 

 

IMPORT & EXPORT ACTIVITIES

 

IMPORT:

·         Types of products

 

Materials

·         Market

 

India, EU, US

 

 

EXPORT:

Note: Currently, the subject does not export

 

 

 

BANKERS

 

VIETTIN BANK PHU THO TRANSACTION OFFICE

Address

 

680 Nguyen Chi Thanh Str, Ward 14 , 11th District, Ho Chi Minh City, Vietnam

Telephone

 

(84-8) 39560976

Fax

 

(84-8) 39560975

 

SHAREHOLDERS

 
We stil have not collected full shareholders in details from registration yet.
 
The subject was known as established by Vietnam Pharmaceutical Corporation, Boston Pharmaceutical Inc. USA and other individual shareholders

 

 

FINANCIAL HIGHLIGHT

 

 

BALANCE SHEET

Unit: One million VND

Balance sheet date

31/12/2009

Number of weeks

52

ASSETS

A. Current Asset

15,625

Receivables

1,595

Inventory

10,133

Cash and other current assets

3,897

B. Long term Asset

126,761

1. Long term account receivable

0

2. Fixed assets

126,761

Tangible fixed assets

1,818

+ Original cost

1,818

+ Accumulated depreciation value

0

Financial leasehold assets

0

Intangible fixed assets

5,095

Construction in progress and other long term asset

119,848

TOTAL ASSETS

142,386

 

LIABILITIES

Payable loans

92,304

Owner’s Equity

50,082

TOTAL LIABILITY AND EQUITY

142,386

 

PROFIT & LOSS STATEMENT

 

1. Total Sales

2,543

2. Deduction item

5

3. Net sale

2,538

4. Costs of goods sold

1,707

5. Gross profit

831

6. Financial income

 

7. Financial expenses

0

8. Selling expenses and Administrative overheads

1,538

9. Net operating profit

-707

10. Other income

 

11. Other expenses

0

12. Other profit /(loss)

 

13. Total accounting profit before tax

-707

14. Current corporate income tax

0

15. Deferred corporate income tax

 

16. Interest from subsidiaries/related companies

 

17. Profit after tax

-707

 

 

PAYMENT HISTORY & PERFORMANCE EXPERIENCES

 

Trade Morality

 

Normal

Liquidity

 

N/A

Payment status

 

N/A

Financial Situation

 

Average

Development trend

 

N/A

Litigation data

 

No Record

Bankruptcy

 

No Record

Sale Methods

 

Wholesaler

Public opinion

 

Normal

 

 

CREDIT INQUIRY: 125,000 USD D/A terms

Caution needed

 

 

INTERPRETATION ON THE SCORES

 

The subject was established in 2007 by Vietnam Pharmaceutical Corporation, Boston Pharmaceutical Inc. USA and other individual shareholders.

The subject specialized in manufacturing and distributing pharmaceutical products, supplement foods with quality is equivalent with foreign pharmaceutical products imported from EU, USA. The subject was granted for GMP WHO, VSATTP certificate in 2009. At the present, the subject manufactured about 100 kinds of products which were distributed throughout country.

Most of assembly was imported from G7 countries such as US, Germany… So, the premises and facilities are adaptable with international standard. Addition to, the subject has built up professional human recourses.

The B credit estimates on the subject reflects that the subject has capacity to meet with small business commitments.

 

APPENDIX

 

INDUSTRY DATA

 

Industry code

Growth speed by price compared with 1994 (%)

Total enterprises 2009

Total employees 2010

(Thous.pers.)

Annual average capital of enterprises 2009

(billion dongs)

2010

2009

Agriculture, Forestry and Fishing

2.78

1.82

8,749

23,896.3

81,559

Industry and Construction

7.70

5.52

85,115

10,630

2,751,975

Trade and Services

7.52

6.63

154,978

14,522

4,939,069

 

ECONOMIC INDICATORS

 

 

2010 

2009 

2008 

Population (Million person)

86.93

86.02

86.1

Gross Domestic Products (US$ billion)

102.2

91

84.9

GDP Growth (%)

6.78

5.32

6.2

GDP Per Capita (US$)

1,160

1,080

1,040

Inflation (% Change in Composite CPI)

11.75

6.88

24.4

 

SERVICE TRADE PERFORMANCE

 

Billion USD 

2010 

2009 

2008 

Exports

72.2

57.1

62.7

Imports

84.8

69.9

80.7

Trade Balance

-12.6

-12.8

-18

Source: General Statistics Office


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.52.96

UK Pound

1

Rs.82.04

Euro

1

Rs.68.91

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.